<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34424253</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>174</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/62936</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a neurodegenerative disorder causing progressive muscle weakness and death within 2-5 years following diagnosis. Clinical manifestations include weight loss, dyslipidemia, and hypermetabolism; however, it remains unclear how these relate to motor neuron degeneration. Using a Drosophila model of TDP-43 proteinopathy that recapitulates several features of ALS including cytoplasmic inclusions, locomotor dysfunction, and reduced lifespan, we recently identified broad ranging metabolic deficits. Among these, glycolysis was found to be upregulated and genetic interaction experiments provided evidence for a compensatory neuroprotective mechanism. Indeed, despite upregulation of phosphofructokinase, the rate limiting enzyme in glycolysis, an increase in glycolysis using dietary and genetic manipulations was shown to mitigate locomotor dysfunction and increased lifespan in fly models of TDP-43 proteinopathy. To further investigate the effect on TDP-43 proteinopathy on glycolytic flux in motor neurons, a previously reported genetically encoded, FRET-based sensor, FLII12Pglu-700&#xb5;&#x3b4;6, was used. This sensor is comprised of a bacterial glucose-sensing domain and cyan and yellow fluorescent proteins as the FRET pair. Upon glucose binding, the sensor undergoes a conformational change allowing FRET to occur. Using FLII12Pglu-700&#xb5;&#x3b4;6, glucose uptake was found to be significantly increased in motor neurons expressing TDP-43<sup>G298S</sup>, an ALS causing variant. Here, we show how to measure glucose uptake, ex vivo, in larval ventral nerve cord preparations expressing the glucose sensor FLII12Pglu-700&#xb5;&#x3b4;6 in the context of TDP-43 proteinopathy. This approach can be used to measure glucose uptake and assess glycolytic flux in different cell types or in the context of various mutations causing ALS and related neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Loganathan</LastName><ForeName>Suvithanandhini</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ball</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzo</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, University of Arizona, Tucson; Vollum Institute, Oregon Health and Science University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarnescu</LastName><ForeName>Daniela C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Molecular and Cellular Biology, University of Arizona, Tucson; Department of Neuroscience, University of Arizona, Tucson; zarnescu@arizona.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM136536</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS091299</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS115514</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 GM062584</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS091299</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures. The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34424253</ArticleId><ArticleId IdType="mid">NIHMS1847132</ArticleId><ArticleId IdType="pmc">PMC9643010</ArticleId><ArticleId IdType="doi">10.3791/62936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ingre C, Roos PM, Piehl F, Kamel F, Fang F Risk factors for amyotrophic lateral sclerosis. Clinical Epidemiology. 7, 181&#x2013;193 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology. 10 (1), 75&#x2013;82 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. The Journal of Biological Chemistry. 276 (39), 36337&#x2013;36343 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neuroscience. 14 (4), 459&#x2013;468 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nature Neuroscience. 14 (4), 452&#x2013;458 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 79 (3), 416&#x2013;438 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS et al. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Human Molecular Genetics. 20 (12), 2308&#x2013;2321 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS et al. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Disease Models &amp; Mechanisms. 6 (3), 721&#x2013;733 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 8, e45114 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkenhoff A, Hirrlinger J, Kappel JM, Klambt C, Schirmeier S Live imaging using a FRET glucose sensor reveals glucose delivery to all cell types in the Drosophila brain. Journal of Insect Physiology. 106 (Pt 1), 55&#x2013;64 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28733241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehr M, Lalonde S, Lager I, Wolff MW, Frommer WB In vivo imaging of the dynamics of glucose uptake in the cytosol of COS-7 cells by fluorescent nanosensors. The Journal of Biological Chemistry. 278 (21), 19127&#x2013;19133 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12649277</ArticleId></ArticleIdList></Reference><Reference><Citation>Takanaga H, Chaudhuri B, Frommer WB GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochimedica et Biophysica Acta. 1778 (4), 1091&#x2013;1099 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2315637</ArticleId><ArticleId IdType="pubmed">18177733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara R et al. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Human Molecular Genetics. 22 (22), 4474&#x2013;4484 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23804749</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand AH, Perrimon N Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 118 (2), 401&#x2013;415 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Garcia CM et al. Quantitative in vivo imaging of neuronal glucose concentrations with a genetically encoded fluorescence lifetime sensor. Journal of Neuroscience Research. 97 (8), 946&#x2013;960 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565483</ArticleId><ArticleId IdType="pubmed">31106909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mergenthaler P, Lindauer U, Dienel GA, Meisel A Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends in Neurosciences. 36 (10), 587&#x2013;597 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900881</ArticleId><ArticleId IdType="pubmed">23968694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Vogel H Drosophila models of neurodegenerative diseases. Annual Review of Pathology. 4, 315&#x2013;342 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3045805</ArticleId><ArticleId IdType="pubmed">18842101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>